Hypopituitarism After External Irradiation

Evidence for Both Hypothalamic and Pituitary Origin

  1. N. A. SAMAAN, M.D., Ph.D., F.R.C.P., F.A.C.P.;
  2. M. M. BAKDASH, M.D.;
  3. J. B. CADERAO, M.D.;
  4. A. CANGIR, M.D.;
  5. R. H. JESSE, Jr., M.D., F.A.C.S.; and
  6. A. J. BALLANTYNE, M.D., F.A.C.S.
  1. Houston, Texas

    Abstract

    Endocrine complications after radiotherapy for tumors of the head and neck are thought to be relatively rare. The availability of synthetic hypothalamic hormones for clinical investigations and the radioimmunoassay of hormones have enabled us to study function of the hypothalamic pituitary axis in 15 patients who had radiotherapy for nasopharyngeal cancer. Fourteen had evidence of endocrine deficiency. Twelve patients had evidence of hypothalamic dysfunction, 7 developed primary pituitary hormone deficiencies, and 3 developed primary hypothyroidism. These results indicate that [1] secondary hypopituitarism due to a hypothalamic lesion after radiotherapy for nasopharyngeal cancer may be more common than suspected in the past; [2] primary hypopituitarism after irradiation of extracranial tumors can occur; and [3] primary hypothyroidism may result from irradiation of regional neck nodes.

    Article and Author Information

    • ▸From the Section of Endocrinology, Department of Medicine, and the Departments of Radiotherapy, Pediatrics, and Surgery, the University of Texas System Cancer Center M. D. Anderson Hospital and Tumor Institute, Houston, Texas.

    • Grant support: by U.S. Public Health Service, National Institutes of Health, grant CA-05831-14, and the American Cancer Society grant CI-78C.

    • ▸Requests for reprints should be addressed to N. A. Samaan, M.D., Ph.D., Section of Endocrinology, The University of Texas System Cancer Center M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave., Houston, TX 77025.

      • Received June 2, 1975.
      • Accepted July 9, 1975.
    « Previous | Next Article »Table of Contents